Affibody AB logo

Affibody AB

94 employees · est. 1998 · Sweden

VS
ProfoundBio logo

ProfoundBio

An oncology biotherapeutics company

8 employees · est. 2018 · Woodinville, United States

Affibody AB is the older company (1998 vs 2018); Affibody AB is the larger of the two.

Side-by-Side Comparison

Affibody AB ProfoundBio
Founded
1998 older 2018
Headquarters
Sweden Woodinville, United States
Employees
94 larger 8
Industry
Biotechnology, Health Care Biotechnology, Health and Wellness
Funding Stage
Debt Financing Series B
Total Funding
$220.00M $247.00M
Funding Rounds
3 4
Services
Development of radiopharmaceutical therapeutics, Research and development in radioligand therapies, Partnerships in immunology Not tracked yet
Target Customers
Cancer patients, Healthcare providers, Pharmaceutical partners Not tracked yet
Taxonomy
Not tracked yet Antibody-based Therapeutics, Clinical-stage, Cancer Research, ADC Drug Candidates, Solid Tumors, Hematological Malignancies, Proprietary Technology, Seattle, Cancer Treatment, Innovative Drug Development, Oncology, Targeted Therapy, Precision Medicine
Website
affibody.com profoundbio.com
Affibody AB logo

About Affibody AB

Affibody AB, founded in 1998 by researchers from the Royal Institute of Technology and the Karolinska Institute, is a private, clinical-stage biotech company based in Stockholm, Sweden. The company operates within the Biotechnology and Health Care industries, focusing on next-generation biotherapeut...

ProfoundBio logo

About ProfoundBio

ProfoundBio is a clinical-stage biotechnology company founded in 2018. The company is focused on developing novel antibody-based therapeutics with curative potential for patients with cancer. ProfoundBio has a pipeline of multiple antibody-drug conjugate (ADC) drug candidates targeting solid tumors...

We will tell you when either one moves

BounceWatch watches Affibody AB and ProfoundBio for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Affibody AB and ProfoundBio — by email.

Frequently Asked Questions

Affibody AB. ProfoundBio — An oncology biotherapeutics company. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Affibody AB has raised $220.00M while ProfoundBio has raised $247.00M.
Affibody AB and ProfoundBio operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Affibody AB with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Affibody AB on 15 Jun 2026, and ProfoundBio on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy